ES2171183T3 - Analogos y conjugados de piperidina con procainamida y napa. - Google Patents

Analogos y conjugados de piperidina con procainamida y napa.

Info

Publication number
ES2171183T3
ES2171183T3 ES95908752T ES95908752T ES2171183T3 ES 2171183 T3 ES2171183 T3 ES 2171183T3 ES 95908752 T ES95908752 T ES 95908752T ES 95908752 T ES95908752 T ES 95908752T ES 2171183 T3 ES2171183 T3 ES 2171183T3
Authority
ES
Spain
Prior art keywords
conjugates
napa
procainamide
derivatives
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95908752T
Other languages
English (en)
Inventor
Gerald F Sigler
Charles F Walter
Todd Glancy
Franck E Klein
Erasmus Huber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics Corp
Original Assignee
Roche Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Corp filed Critical Roche Diagnostics Corp
Application granted granted Critical
Publication of ES2171183T3 publication Critical patent/ES2171183T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE DESCRIBEN NUEVOS DERIVADOS DE PROCAINAMIDA Y NACETILPROCAINAMIDA (NAPA) QUE TIENEN LA FORMULA (1) EN DONDE: X = HIDROGENO O ACETILO; N = 1 A P DONDE P = MW DE Z/1000; Z = UN POLI(AMINOACIDO) O POLISACARIDO; Y R3 = UN ENLACE O (2) EN DONDE R2 = UN GRUPO ALQUILO, CICLOALQUILO O ARILO QUE TIENE DE 2 A 10 ATOMOS DE CARBONO. LOS DERIVADOS INCLUYEN CONJUGADOS DE MALEIMIDA DE PROTEINAS O POLI(AMINOACIDOS), ENZIMAS, POLIPEPTIDOS DONANTES DE ENZIMA Y SUSTANCIAS DE MARCACION. TAMBIEN SE DESCRIBEN NUEVOS CONJUGADOS ACTIVADOS Y METODOS PARA LA SINTESIS DE LOS INTERMEDIARIOS Y DERIVADOS DE HAPTENO.
ES95908752T 1994-01-31 1995-01-31 Analogos y conjugados de piperidina con procainamida y napa. Expired - Lifetime ES2171183T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/190,348 US5525474A (en) 1994-01-31 1994-01-31 Piperidine analogs and conjugates of procainamide and NAPA

Publications (1)

Publication Number Publication Date
ES2171183T3 true ES2171183T3 (es) 2002-09-01

Family

ID=22700969

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95908752T Expired - Lifetime ES2171183T3 (es) 1994-01-31 1995-01-31 Analogos y conjugados de piperidina con procainamida y napa.

Country Status (8)

Country Link
US (1) US5525474A (es)
EP (1) EP0742903B1 (es)
JP (1) JP3031636B2 (es)
AU (1) AU682931B2 (es)
CA (1) CA2181898A1 (es)
DE (1) DE69525038T2 (es)
ES (1) ES2171183T3 (es)
WO (1) WO1995020763A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439798A (en) * 1993-12-17 1995-08-08 Boehringer Mannheim Corporation Maleimide adduct conjugates of procainamide and NAPA
EP0931062B1 (en) * 1997-05-27 2004-11-17 Microgenics Corporation Conjugates and specific immunoassays for the methadone metabolite 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine
US6262265B1 (en) 1999-06-18 2001-07-17 Microgenics Corporation Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
US7279340B2 (en) * 2004-04-07 2007-10-09 Dade Behring Inc. Synthesis and application of procainamide analogs for use in an immunoassay
CN104640572B (zh) 2012-05-15 2018-04-27 索伦托医疗有限公司 药物偶联物，偶联方法，及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235969A (en) * 1978-05-08 1980-11-25 Syva Company Procainamide antigen conjugates and antibodies
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4673763A (en) * 1983-01-03 1987-06-16 Miles Laboratories, Inc. Alpha-functionalized derivatives and labeled conjugates of procainamide and NAPA
EP0199042A1 (en) * 1985-03-26 1986-10-29 Abbott Laboratories Procainamide assay, tracers, immunogens and antibodies
US5439798A (en) * 1993-12-17 1995-08-08 Boehringer Mannheim Corporation Maleimide adduct conjugates of procainamide and NAPA

Also Published As

Publication number Publication date
EP0742903B1 (en) 2002-01-16
CA2181898A1 (en) 1995-08-03
US5525474A (en) 1996-06-11
JPH09508393A (ja) 1997-08-26
DE69525038T2 (de) 2002-08-29
EP0742903A4 (en) 2000-04-05
AU682931B2 (en) 1997-10-23
AU1697095A (en) 1995-08-15
EP0742903A1 (en) 1996-11-20
JP3031636B2 (ja) 2000-04-10
WO1995020763A1 (en) 1995-08-03
DE69525038D1 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK97987D0 (da) Solubilisering af proteiner til farmaceutiske sam mensaetninger under anvendelse af polymerkonjugation
ES2072779T3 (es) Derivados aminoacidos anfoteros.
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
PT98205A (pt) Processo para a preparacao de novos derivados beta-lactamicos
CO4700452A1 (es) Derivados de indol
BR0004535A (pt) Compostos, e, uso dos mesmos.
PT83535B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
DK0882726T3 (da) Carbazolcarboxamider som 5-HT1F-agonister
ES2171183T3 (es) Analogos y conjugados de piperidina con procainamida y napa.
ES2059688T3 (es) Derivados de aminoacidos inhibidores de enzimas, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
ES2055830T3 (es) Derivados de cromano.
CO5210883A1 (es) DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO [4,5,-b]INDOL- 1-ACETAMIDA
DK0863868T3 (da) Fremgangsmåde til fremstilling af 1-aryl-1-cyanocyclobutanderivater
DE69012619D1 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
ES2059767T3 (es) Derivado de 1,4-dihidropiridina.
SE8602523L (sv) 2-alkyl- eller -aralkyltio-1-cykloalken-1-karboxamider och deras sulfoxider, sett for deras framstellning och deras anvendning for syntes av tri- och 4,5-tetrametylen-4-isotiazolin-3-oner
DK615886D0 (da) Substituerede gamma-thiobutyrolactoner til anvendelse som antikonvulsiva
PT99360A (pt) Processo para a preparacao de carbamatos de oxi-sulfonilo e de composicoes farmaceuticas que os contem
ES2087883T3 (es) Derivados de politetrahidrofurano con grupos aromaticos terminales.
ES2185555T3 (es) Derivados de calixarenos para la extraccion de actinidos.
ES2156099T1 (es) Metodo para tratar sustratos metalicos usando polieteres derivados de mannich.
YU2994A (sh) Prolekovi antinflamatornih 3-acil-2-oksindol-1-karboksamida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 742903

Country of ref document: ES